Comirnaty Concentrate For Dispersion For Injection 0,3 mL Concentrate for dispersion for injection
Try these: Panado Ivedal Zometa Zofaril

Comirnaty Concentrate For Dispersion For Injection 0,3 mL Concentrate for dispersion for injection

S4
PDF Leaflet Revision Date: 23 August 2023
API: Covid-19 Mrna Vaccine (Embedded In Lipid Nanoparticles) | Company: Pfizer Laboratories

Clinical Summary

Quick overview from the medicine insert

Indication

Active immunisation to prevent COVID-19 in individuals 12 years and older.

Dosage (summary)

Primary course: 2 doses (0.3 mL each) IM, 3 weeks apart; booster: 0.3 mL IM.

Special Populations

  • Elderly
  • Severely immunocompromised

Pregnancy & Breastfeeding

Can be used during pregnancy and breastfeeding; no adverse effects expected.

Contraindications

  • Hypersensitivity to vaccine components

Common side effects

  • Injection site pain
  • Fatigue
  • Headache
  • Myalgia
  • Chills

Counselling Points

  • Monitor for 15 mins post-vaccination
  • Report any severe reactions immediately

Serious warnings

  • Risk of anaphylaxis
  • Increased risk of myocarditis and pericarditis

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Comirnaty Concentrate For Dispersion For Injection 0,3 mL Concentrate for dispersion for injection
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW